RxDoctor Payments Data

Robert Jackson, MD

Family Medicine · Gaffney, SCNPI 1710965637

Payments from drug & device makers

$3,622in general payments, 2019–2025

Across 221 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$426
  • Lilly USA, LLC$298
  • AstraZeneca$256
  • Pfizer$226
  • Boehringer Ingelheim$204
  • Amgen$159
  • plus $2K from 41 others

What the payments were for

  • Food & beverage$3,605100%
  • Education$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,622 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$1,351
Medicare patients
13
Services billed
24

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide221$235,499
MounjaroTirzepatide113$117,731
EliquisApixaban100$97,398
TrulicityDulaglutide56$73,224
JanuviaSitagliptin Phosphate50$51,610
XareltoRivaroxaban28$43,414
JardianceEmpagliflozin42$42,630
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$39,294
TradjentaLinagliptin20$29,567
LinzessLinaclotide34$25,974
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog33$25,377
FarxigaDapagliflozin Propanediol26$24,724
Repatha SureclickEvolocumab33$24,144
EntrestoSacubitril/Valsartan25$22,608
MyrbetriqMirabegron23$21,248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$137$235,499221 claims
Lilly USA, LLCMounjaro, Trulicity$298$190,955169 claims
PfizerEliquis, Premarin$226$101,433113 claims
Boehringer IngelheimJardiance, Tradjenta$204$72,19762 claims
MerckJanuvia, Janumet$19$60,05063 claims
AbbVieLinzess, Vraylar, Synthroid$426$49,87086 claims
Johnson & JohnsonXarelto$29$43,41428 claims
GSKTrelegy Ellipta$124$39,29436 claims
AstraZenecaFarxiga, Symbicort$256$36,13963 claims
NovartisEntresto$101$22,60825 claims
Astellas Pharma US IncMyrbetriq$98$21,24823 claims
Esperion Therapeutics, Inc.Nexletol$44$11,90818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Gaffney

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →